KATHLEEN MAGUIRE: Open Payments
NPI 1710005475 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 21 payments from 10 companies in 2025. Trend: 2023 $457 · 2024 $151 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $178 |
| Lilly USA, LLC | 4 | $166 |
| Exact Sciences Corporation | 2 | $40 |
| Corium, LLC | 1 | $33 |
| Amgen Inc. | 2 | $30 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
Products named: CAPLYTA, ZEPBOUND, Azstarys, EVENITY, NUZYRA, MOUNJARO, Cologuard Collection Kit, PAXLOVID.
Industry payments across CO — which companies pay providers there.
